$7.71
13.55% yesterday
Nasdaq, May 20, 09:49 pm CET
ISIN
BE0974358906
Symbol
NYXH

Nyxoah SA Stock price

$7.70
+1.76 29.63% 1M
-0.51 6.21% 6M
-0.30 3.75% YTD
-2.30 23.00% 1Y
-5.71 42.59% 3Y
-11.80 60.51% 5Y
-11.80 60.51% 10Y
Nasdaq, Closing price Tue, May 20 2025
+0.91 13.40%
ISIN
BE0974358906
Symbol
NYXH
Sector

Key metrics

Market capitalization $264.78m
Enterprise Value $220.54m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 47.02
P/S ratio (TTM) P/S ratio 56.46
P/B ratio (TTM) P/B ratio 2.87
Revenue growth (TTM) Revenue growth -15.58%
Revenue (TTM) Revenue $4.69m
EBIT (operating result TTM) EBIT $-73.00m
Free Cash Flow (TTM) Free Cash Flow $-59.10m
Cash position $68.10m
EPS (TTM) EPS $-2.13
P/E forward negative
P/S forward 19.65
EV/Sales forward 16.36
Short interest 0.47%
Show more

Is Nyxoah SA a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Nyxoah SA Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Nyxoah SA forecast:

7x Buy
78%
2x Hold
22%

Analyst Opinions

9 Analysts have issued a Nyxoah SA forecast:

Buy
78%
Hold
22%

Financial data from Nyxoah SA

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
4.69 4.69
15% 15%
100%
- Direct Costs 4.71 4.71
0% 0%
100%
-0.02 -0.02
102% 102%
0%
- Selling and Administrative Expenses 33 33
62% 62%
696%
- Research and Development Expense 37 37
30% 30%
794%
-70 -70
46% 46%
-1,491%
- Depreciation and Amortization 3.09 3.09
18% 18%
66%
EBIT (Operating Income) EBIT -73 -73
44% 44%
-1,557%
Net Profit -75 -75
60% 60%
-1,593%

In millions USD.

Don't miss a Thing! We will send you all news about Nyxoah SA directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Nyxoah SA Stock News

Neutral
Seeking Alpha
6 days ago
Nyxoah SA (NASDAQ:NYXH ) Q1 2025 Earnings Conference Call May 14, 2025 8:00 AM ET Company Participants Pearson Dennis - Investor Relations Olivier Taelman - Chief Executive Officer John Landry - Chief Financial Officer Conference Call Participants Jon Block - Stifel Adam Maeder - Piper Sandler Ross Osborn - Cantor Fitzgerald Suraj Kalia - Oppenheimer & Co. David Rescott - Baird Michael Polark -...
Neutral
GlobeNewsWire
7 days ago
REGULATED INFORMATION Nyxoah Reports First Quarter Financial and Operating Results Company On Track for Anticipated PMA Approval in the Second Quarter of 2025 Successfully Completed FDA Validation Requirements, Final Site Inspection in Progress Mont-Saint-Guibert, Belgium – May 14, 2025, 7am CET / 1am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technol...
Neutral
GlobeNewsWire
11 days ago
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), May 9, 2025 , 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below. FMR LLC On May 2, 2025, Nyxoah receive...
More Nyxoah SA News

Company Profile

Nyxoah SA engages in the research and development, manufacture and sale of medical devices. It focuses on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Its lead solution platform is based on the Genio system, a validated, user-centered, neurostimulation therapy for obstructive sleep apnea (OSA). The company was founded by Robert Taub and Adi Mashiach on July 15, 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Head office Belgium
CEO Olivier Taelman
Employees 183
Founded 2009
Website www.nyxoah.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today